Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l -DOPA treatment and changes in levodopa-induced dyskinesia-Reference-Cited by-同舟云学术

Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l -DOPA treatment and changes in levodopa-induced dyskinesia

Published:2017-03-30 Issue:4 Volume:141 Page:614-625
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Andersen Andreas Dammann¹²³⁴^ORCID,Blaabjerg Morten⁵⁶⁷,Binzer Michael²³,Kamal Akram⁶,Thagesen Helle⁶,Kjaer Troels Wesenberg⁶,Stenager Egon¹²³⁸,Gramsbergen Jan Bert Paul⁹

Affiliation:

1. Department of Neurology; Hospital of Southern Jutland; Sønderborg Denmark

2. Institute of Regional Health Research; Center of Southern Jutland; University of Southern Denmark; Aabenraa Denmark

3. Focused Research Group in Neurology; Hospital of Southern Jutland; Aabenraa Denmark

4. Odense Patient data Exploratory Network; Odense University Hospital; Odense Denmark

5. Department of Neurology; Odense University Hospital; Odense Denmark

6. Department of Neurology; Zealand University Hospital; Roskilde Denmark

7. Department of Clinical Research; University of Southern Denmark; Odense Denmark

8. The Multiple Sclerosis Clinic of Southern Jutland; Vejle, Sonderborg, Esbjerg Denmark

9. Institute of Molecular Medicine; Neurobiological Research; University of Southern Denmark; Odense Denmark

Funder

Syddansk Universitet

Region of Southern Denmark

Hospital of Southern Jutland

A.P. Møller Foundation for the Advancement of Medical Science

Parkinsonforeningen

Michael J. Fox Foundation for Parkinson's Research

Memorial Foundation of Knud and Edith Eriksen

Danske Bank's Foundation

Else Poulsens Memorial Scholarship

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jnc.13997/fullpdf

Reference60 articles.

1. Cerebrospinal fluid homovanillic acid in the DATATOP study on Parkinson's disease. Parkinson Study Group;Parkinson Study Group;Arch. Neurol.,1995

2. Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease;Abdo;Mov. Disord.,2004

3. Effects of noradrenergic denervation on l-DOPA-induced dyskinesia and its treatment by alpha- and beta-adrenergic receptor antagonists in hemiparkinsonian rats;Barnum;Pharmacol. Biochem. Behav.,2012

4. The metabolic pathways of L-3-O-methyldopa;Bartholini;J. Pharmacol. Exp. Ther.,1972

5. Pathophysiology of l-DOPA-induced motor and non-motor complications in Parkinson's disease;Bastide;Prog. Neurobiol.,2015

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age specific neuroprotection of curcumin is through differential modulation of brain dopamine metabolism: Insights from Drosophila model of Parkinson’s disease;2024-07-27

2. Identification of volatile metabolites produced from levodopa metabolism by different bacteria strains of the gut microbiome;BMC Microbiology;2024-07-13

3. Cannabinoid Modulation of Monoamine Levels in Mouse Brain: Unveiling Neurochemical Dynamics through an Innovative High-performance Liquid Chromatography-Fluorescence Detection Bioanalysis;Journal of Analysis and Testing;2024-05-16

4. Microfluidic flow injection analysis system for the electrochemical detection of dopamine using diazonium-grafted copper nanoparticles on multi-walled carbon nanotube-modified surfaces;Talanta;2024-01

5. Identification of volatile metabolites produced from gut microbial levodopa metabolism using an untargeted metabolomics approach;2023-09-19